Institutional investors hold a majority ownership of MRK through the 75.52% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2013, these large investors purchased a net $1.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 2.3 Million shares of Merck & Co Inc
PYRAMIS GLOBAL ADVISORS (CANADA)... Bought 491.4 Thousand shares of Merck & Co Inc
STRATEGIC ADVISERS, INC. Bought 349.4 Thousand shares of Merck & Co Inc